Study Objectives: To complete a systematic review and meta-analysis on the frequency of endotracheal intubation among out-of-hospital and emergency department (ED) patients receiving ketamine for acute agitated delirium.
Study Objectives: To complete a systematic review and meta-analysis on the frequency of endotracheal intubation among out-of-hospital and emergency department (ED) patients receiving ketamine for acute agitated delirium.
Methods: We searched MEDLINE, Embase, CINAHL, Web of Science, and clinical trial registries using search terms aided by a librarian. We included studies of patients receiving ketamine for agitation in the out-of-hospital or ED settings that reported subsequent endotracheal intubation as an adverse event. We identified 136 studies (excluding duplicates), and 120 studies were excluded based on the abstract alone. 16 studies underwent full review for inclusion by the authors, and 12 studies were included. GRADE methodology was used to assess the quality of the included studies.
Results: Among the 12 included studies, 527 patients were included in the analysis. 423 patients were included in the 9 out-of-hospital studies, and 104 patients were included in the 3 ED studies. All patients received ketamine via intramuscular administration. According to GRADE methodology, 7 of the out-of-hospital studies were retrospective and determined to be of low or very low quality of evidence. The 2 remaining out-of-hospital studies were prospective and determined to be of moderate quality. Among the 3 ED studies, 2 prospective studies received a rating of moderate quality while the remaining retrospective study received a rating of low quality. The pooled frequency of intubation among patients receiving ketamine sedation in both settings was 18.5% (159/527) (95% CI 9.7 -32.0). In the subgroup analysis among the patients receiving ketamine for sedation in the ED, the frequency of intubation was 1.1% (2/104) (95% CI 1.1 -7.3). The mean difference between intubation rates among the out-of-hospital and ED settings after ketamine sedation was 28.9% (95% CI 22.9 -33.5).
Conclusions: The frequency of endotracheal intubation after the use of ketamine for sedation of patients with acute agitated delirium appears to be high in the out-ofhospital and ED literature. However, when ketamine sedation is administered in the ED, the frequency of intubation is substantially lower and appears to be safe. Further studies are needed to address the disparate rate of endotracheal intubation after ketamine sedation among the out-of-hospital and ED environments. Study Objectives: Patients with mental health-related ED visits often have prolonged ED lengths of stay (LOS). As mental health ED visits are increasingly common, safely shortening LOS could benefit patients and EDs. Early discontinuation of involuntary mental health holds (holds) in appropriate patients could potentially improve ED throughput and alleviate shortage of psychiatric inpatient beds. Suicide risk, common diagnoses and need for parental involvement vary between pediatric and adult patients, and it is possible that psychiatrists who primarily treat adults practice differently than child and adolescent psychiatrists. The study objective was to determine if the probability of hold discontinuation for pediatric patients varied based on whether a child and adolescent psychiatrist or a general emergency psychiatrist performed the initial ED evaluation.
Methods: This is a retrospective study of patients on holds in a single ED from July 1, 2016 -June 30, 2017. All patients under 18 years of age with a hold initiated prior to ED arrival who presented from 3 pm-midnight weekdays and 9 am-6 pm weekends were included. These times were selected because arriving patients could be seen either by child and adolescent or general emergency psychiatry based on psychiatry service staffing.
The primary outcome of interest was hold discontinuation after initial psychiatry evaluation. Multivariate logistic regression adjusting for patient age, sex, language, hold indication, agency initiating hold, and time and day of arrival was performed.
Results: 393 patients met inclusion criteria. 186 were evaluated by 1 of 10 child and adolescent psychiatrists and 207 by 1 of 16 general emergency psychiatrists. 27.4% of holds (51/186) were discontinued after initial evaluation by a child and adolescent psychiatrist and 10.6% of holds (22/207) were discontinued after general emergency psychiatrist evaluation (p <0.001). A sensitivity analysis of patients arriving from 3 pm -7 pm weekdays and 3 pm -6 pm weekends also found that child and adolescent psychiatrists were likelier to discontinue holds than general emergency psychiatrists (p¼0.001).
After adjusting for potential confounders, holds were much more likely to be discontinued in patients evaluated by a child and adolescent psychiatrist rather than a general emergency psychiatrist (adjusted OR 3.0, 95% CI 1.6-5.7).
Conclusions: Pediatric patients had 3 times the odds of hold discontinuation if evaluated by a child and adolescent rather than a general emergency psychiatrist. While the ideal hold discontinuation rate is unknown, this variation is concerning. Involuntary treatment should be reserved for situations in which less restrictive means are not possible. As such, the odds of hold discontinuation should not vary markedly based on the subspecialty of the consulting psychiatrist.
Additionally, inpatient psychiatric beds are limited, contributing to prolonged ED LOS for patients requiring inpatient care. While lack of psychiatric beds is a multifactorial problem, reducing inappropriate use of inpatient beds for involuntary patients who could safely be treated as outpatients could alleviate this shortage.
Alternatives such as regionalization of pediatric mental health emergency care, telemedicine, and additional pediatric training for emergency psychiatrists should be investigated to reduce variation in care. Study Objectives: Subgroup analyses were conducted to evaluate abstinence among adults with a history of opioid injection use versus non-injecting opioid users in a phase III study (NCT02357901) of RBP-6000, an extended-release monthly depot formulation of buprenorphine for opioid use disorder (OUD).
Methods: Adults with moderate to severe OUD were randomized to RBP-6000 300/100mg, RBP-6000 300/300mg or placebo for 24 weeks. Both RBP-6000 dosing regimens started with 2 monthly injections of 300mg, then either 100mg or 300mg for injections 3-6. Abstinence was defined as opioid-negative urine samples and self-reports negative for illicit opioid use. Percentage abstinence was evaluated for weeks 5-24 and weeks 10-25 (ie, excluding participants who discontinued prior to injection 3 on week 9); continuous abstinence was also evaluated for weeks 21-24. The risk-adjusted difference between 300/100mg and 300/300mg regimens was estimated using inverse propensity weighting with propensity score to balance risk factors prior to injection 3.
Results: At screening, 214 participants had injected opioids (300/300mg, n¼80; 300/100mg, n¼84; placebo, n¼50) and 274 had not injected opioids (300/300mg, n¼115; 300/100mg, n¼110; placebo, n¼49). Among injecting opioid users, mean percentage abstinence (weeks 5-24, weeks 10-25) was higher for 300/300mg (45%, 58%) than 300/100mg (36%, 43%) or placebo (7%, 10%). After risk adjustment, the mean percentage abstinence difference (weeks 10-25) between 300/300mg and 300/
